The IL-17 cytokine (related to the lesion activity) was recently detected in the human serum of autoimmune diseases, and it is frequently high in blood and cerebrospinal fluid of MS individuals, who were not subjected to treatment with IFN, and reduced in remission periods [35]. Here, IL17A is linked to myeloid sarcoma.